We are live on
!
Find out more
RHAM
Round Hill Asset Management Portfolio holdings
AUM
$153M
1-Year Est. Return
6.67%
This Fund
S&P 500
This Quarter
Est. Return
+3.09%
1 Year Est. Return
+6.67%
3 Year Est. Return
+40.66%
5 Year Est. Return
+39.97%
10 Year Est. Return
–
AUM
$152M
AUM Growth
+$3.81M
(+2.6%)
Cap. Flow
+$1.82M
Cap. Flow
% of AUM
1.2%
Top 10 Holdings %
Top 10 Hldgs %
50.33%
Holding
64
New
3
Increased
7
Reduced
24
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Concentrix
CNXC
|
+$1.59M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.16M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$1.09M |
| 4 |
Kenvue
KVUE
|
+$779K |
| 5 |
Atkore
ATKR
|
+$353K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$983K |
| 2 |
Capital One
COF
|
+$887K |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$773K |
| 4 |
Microsoft
MSFT
|
+$528K |
| 5 |
Wells Fargo
WFC
|
+$286K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 30.13% |
| 2 | Healthcare | 28.43% |
| 3 | Communication Services | 18.79% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Technology | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Novartis
NVS
$297B
| $435K | 0.29% |
3,392
| – | – |
|
52
Berkshire Hathaway Class B
BRK.B
$1.13T
| $370K | 0.24% |
735
| – | – |
|
53
InterDigital
IDCC
$8.89B
| $365K | 0.24% |
1,058
| – | – |
|
54
Bank of America
BAC
$442B
| $339K | 0.22% |
6,579
-2,295
| -26% | -$112K |
|
55
Nature's Sunshine
NATR
$288M
| $332K | 0.22% |
21,423
| – | – |
|
56
CME Group
CME
$94.8B
| $329K | 0.22% |
1,219
| – | – |
|
57
TriCo Bancshares
TCBK
$1.83B
| $296K | 0.2% |
6,674
| – | – |
|
|
BLFY
58
DELISTED
Blue Foundry Bancorp
BLFY
| $224K | 0.15% |
24,683
| – | – |
|
59
Lake Shore Bancorp
LSBK
$134M
| $204K | 0.13% |
+15,715
| New | +$211K |
|
60
Viatris
VTRS
$18.9B
| $164K | 0.11% |
16,540
| – | – |
|
61
Gyrodyne
GYRO
| $152K | 0.1% |
15,188
| – | – |
|
62
Organon & Co
OGN
$3.57B
| $143K | 0.09% |
13,366
| – | – |
|
63
Patterson-UTI
PTEN
$3.76B
| $83.6K | 0.06% |
16,134
| – | – |
|
|
PARA
64
DELISTED
Paramount Global Class B
PARA
| – | – |
-59,953
| Closed | -$773K |
|
Similar funds
SGM
HWM
CMMS
APW
FHC
BCI
II
DAM
Round Hill Asset Management's Q3 2025 Portfolio in Review
As of Q3 2025, Round Hill Asset Management held 64 positions worth $152M, up 2.6% from $148M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Round Hill Asset Management's Q3 2025 filing shows 3 new, 7 increased, 24 reduced and 1 closed positions. Its largest new stake was Concentrix: 29,743 shares worth $1.37M. The largest sale was S&P Global, an estimated $983K.
By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.
- Round Hill Asset Management's largest Q3 2025 buy was Concentrix: 29,743 shares worth $1.37M.
- Round Hill Asset Management added most to Bristol-Myers Squibb in Q3 2025, an estimated $1.16M increase.
- Round Hill Asset Management's biggest Q3 2025 reduction was S&P Global, cutting an estimated $983K.
- Round Hill Asset Management fully exited Paramount Global Class B in Q3 2025, selling an estimated $773K.
- Round Hill Asset Management's ten largest holdings make up 50% of its $152M portfolio in Q3 2025.
- Round Hill Asset Management opened 3 new positions and closed 1 in Q3 2025.
- Round Hill Asset Management's portfolio value rose 2.6% quarter-over-quarter to $152M.
Based on Round Hill Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.